Oral delivery of a simple, nontoxic sugar molecule alleviates symptoms of Huntington disease in a mouse model (pages 148–154).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
La Spada, A.R. et al. Nature 352, 77–79 (1991).
Zoghbi, H.Y. & Orr, H.T. Annu. Rev. Neurosci. 23, 217–247 (2000).
Ross, C.A. Neuron 35, 819–822 (2002).
Sanchez, I. et al. Nature 421, 373–379 (2003).
Tanaka, M. et al. Nat. Med. 10, 148–154 (2004).
Tanaka, M. et al. J. Biol. Chem. 276, 45470–45475 (2001)
Klement, I.A. et al. Cell 95, 41–53 (1998).
Yang, W. et al. Hum. Mol. Genet. 11, 2905–2911 (2003).
Katsuno, M. et al. Nat. Med. 9, 768–773 (2003).
Hockly, E. et al. Proc. Natl. Acad. Sci. USA 100, 2041–2046 (2003).
Ferrante, R.J. et al. J. Neurosci. 23, 9418–9427 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Katsuno, M., Adachi, H. & Sobue, G. Sweet relief for Huntington disease. Nat Med 10, 123–124 (2004). https://doi.org/10.1038/nm0204-123
Issue Date:
DOI: https://doi.org/10.1038/nm0204-123